TrialJournal of acquired immune deficiency syndromes (1999)2013

High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.

Tara Perti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.